June 1th
2005
2:08 PM
The indentations are called cutaneous, or sub-cutaneous atrophy. Intra-articular or intra-muscular injection of Kenalog brings the risk of this as does topical application. But when the practitioner does not take care to release the drug into the muscle, rather than the fatty layer above it, the atrophy are almost certain. The use of this drug by health professionals and the fact that Bristol-Myers Squibb has failed to take steps to limit and closely control it's use, are national disgraces. The atrophy is unlikely to improve, and apparently neither is the medical profession or Bristol-Myers Squibb.
Jim
materially
November 30th
2008
6:50 PM
This is an update. I have experienced "some" problems trying to get Doctors to believe that my muscle problems are Lipitor related. I was sent this by a nurse. It is not the full page.
"2005 Mosby's Nursing Drug Reference (pg.155)
atorvastatin
Lipitor
Uses: As an adjunct in primary hypercholesterolemia
Interactiions:
*Risk of possible rhabdomyolysis; azole antifungaals,
cycloSPORINE, erythromycin, niacin, gemfibrozil, clofibrate".
Guess what? I have been using an azole antifungal intermittently for the entire time I was on Lipitor. It is not a medication I "take". It is used topically for a fungal nail which refuses to clear up. You may have been using it for athletes foot.
-- By ant | Reply | (2) replies | Private Message meNow one pharmacist says a topical application cannot cause this interaction and another pharmacist says it is almost certain that the azole antifungal gets into the blood stream and will interact with the Lipitor. I have to laugh.
Next week I start Physical Therapy on my left elbow.